|
End-of-day quote
New Zealand S.E.
18/09/2026
|
5-day change | 1st Jan Change | ||
| 4.300 NZD | +0.23% |
|
-2.05% | +27.22% |
| 09/09 | Aft Pharmaceuticals Limited Partners with Mark Cuban Cost Plus Drug Company to Bring Combogesic to the U.S | CI |
| 31/07 | AFT Pharmaceuticals Limited - Shareholder/Analyst Call |
Chart: Technical Analysis
New Zealand S.E.NZD
| Markets | Quality | ||
|---|---|---|---|
New Zealand S.E.
| AFT | End-of-day quote | |
Australian S.E.
| AFP | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 4.5 | 4.82 | 4.81 |
| Spread/Res. | -4.44% | -10.79% | -10.60% |
| Spread/Supp. | +1.18% | +9.97% | +13.16% |
| Support | 4.25 | 3.91 | 3.8 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AFT Stock
- Charts AFT Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
